Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: CAYMAN CHEMICAL CO INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-03-20 to 2023-05-31
Current total value of award: $22800
Description: IN PHASE 2, B5T-KNOCKOUT I-AB ELUATES (N=3 FROM SP3988), H2-KB PEPTIDE ELUATES, AND H2-DB PEPTIDE ELUATES WILL BE ANALYZED SEPARATELY FROM EACH SAMPLE, THEN SUBMITTED TO MS BIOWORKS FOR PEPTIDE PROFILING. THE TOTAL SAMPLES SUBMITTED FOR MASS SPECTROM